Status:
TERMINATED
PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator?
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Defibrillators, Implantable
Eligibility:
All Genders
18+ years
Brief Summary
The main objective of this study is to determine among the patients included a subpopulation that does not need a defibrillator. This will be done by comparing the number of discordant segments (mism...
Eligibility Criteria
Inclusion
- Patient with ischemic heart disease with heart failure
- Patients who received myocardial perfusion scintigraphy
- Indication for the implantation of an ICD installed according to current recommendations : LVEF \<30% and NYHA (New York Heart Association) stage II, III.
- The subject must have given his informed consent and signed consent
- The subject must be a member or beneficiary of a social security system
Exclusion
- Pregnant or lactating women
- History of "open heart" cardiovascular surgery
- Inability to sign informed consent (patient under guardianship)
- Patients with diabetes mellitus
- Patient with proven dementia
- Person refusing to sign the consent
- Someone who already has an ICD at baseline
- Life expectancy less than one year (NYHA IV, other diseases such as neoplastic disease in an advanced stage)
Key Trial Info
Start Date :
June 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01258283
Start Date
June 1 2011
End Date
June 1 2016
Last Update
February 3 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Nîmes
Nîmes, Gard, France, 30029
2
Centre Hospitalier Universitaire de Montpellier
Montpellier, France